(Date:3/11/2010)... at Philadelphia Conference , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced it will ... Bank and Cowen & Company at CBI,s 2010 Accounting and ... attended each year by over 300 finance, accounting, audit and ...
(Date:3/10/2010)... March 11 Thomson Reuters today announced it has ... Times Higher Education,s influential World University Rankings. The survey reflects ... resource to the global scholarly community. , ... ... ...
(Date:3/10/2010)... today announced the appointment of Mr. Kevin Giese , President, CEO and Director of BioMS Medical and Mr. Laine Woollard, QC , Senior Legal ... ... , ... ... ...
(Date:3/10/2010)... , ... ... ... , ... ...
Breaking Biology Technology:ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 2Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 3Spectral appoints two new board members 2Spectral appoints two new board members 3BR Ventures Invests in Semprae Laboratories 2BR Ventures Invests in Semprae Laboratories 3BR Ventures Invests in Semprae Laboratories 4... Inc.,(Nasdaq: ONTY ) (TSX: ONY) (the "Company") ... in a Phase 1b clinical trial of PX-12 ... proprietary small molecule,inhibitor of thioredoxin, a protein that ... survival and drug resistance of,many cancers., The ...
... lecture and present a poster on proprietary siRNA ... targeting ... Quark Pharmaceuticals, Inc., a,development-stage pharmaceutical company discovering and developing ... the Cambridge Healthcare Institute,s 9th Annual Beyond,Genome Conference on ...
... DURECT Corporation,(Nasdaq: DRRX ) announced today that ... has been submitted to the U.S. Food,and Drug ... long,acting oral formulation of oxycodone intended to treat ... Remoxy is designed to resist,common methods of prescription ...
Other Biology Technology:Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 2Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 3Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 2Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 2New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 4New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 5Biology NavigationMedical Navigation